An exploratory phase II clinical trial of apatinib in progressive radioiodine refractory differentiated thyroid cancer

被引：1
|
作者：
Lin, Yan-Song [1 ]
Zhang, Xin [1 ]
Liu, Yanqing [1 ]
Wang, Chen [1 ]
Zhang, Teng [1 ]
机构：
[1] Peking Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e18094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18094
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-Term Results of a Phase II Trial of Apatinib for Progressive Radioiodine Refractory Differentiated Thyroid Cancer
    Lin, Yan-Song
    Zhang, Xin
    Wang, Chen
    Liu, Yan-Qing
    Guan, Wen-Min
    Liang, Jun
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (08): : E3027 - E3036
  • [2] Pilot Dose Comparison of Apatinib in Chinese Patients With Progressive Radioiodine-Refractory Differentiated Thyroid Cancer
    Zhang, Xin
    Wang, Chen
    Lin, Yansong
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (10): : 3640 - 3646
  • [3] Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma
    Du, Wei
    Shi, Xiangyu
    Fang, Qigen
    Zhang, Xu
    Liu, Shanting
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [4] Clinical guidance for radioiodine refractory differentiated thyroid cancer
    Gild, Matti L.
    Topliss, Duncan J.
    Learoyd, Diana
    Parnis, Francis
    Tie, Jeanne
    Hughes, Brett
    Walsh, John P.
    McLeod, Donald S. A.
    Clifton-Bligh, Roderick J.
    Robinson, Bruce G.
    CLINICAL ENDOCRINOLOGY, 2018, 88 (04) : 529 - 537
  • [5] Effect of Apatinib Prior to Radioiodine therapy in the Treatment of Metastatic Progressive Differentiated Thyroid Cancer
    Shi, Liang
    You, Qinqin
    Wang, Jun
    Wang, Hanjin
    Li, Shaohua
    Tian, Rui
    Yao, Xiaochen
    Wu, Wenyu
    Zhang, Lele
    Wang, Feng
    Lin, Yansong
    Li, Shuren
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [6] Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer
    Lin, Yansong
    Wang, Chen
    Gao, Wen
    Cui, Ruixue
    Liang, Jun
    ONCOTARGET, 2017, 8 (26) : 42252 - 42261
  • [7] Radioiodine refractory differentiated thyroid cancer
    Jin, Yuchen
    Van Nostrand, Douglas
    Cheng, Lingxiao
    Liu, Min
    Chen, Libo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 111 - 120
  • [8] Radioiodine refractory differentiated thyroid cancer
    Boudina, Maria
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2023, 26 : 65 - 68
  • [9] Clinical and molecular profiles of radioiodine refractory differentiated thyroid cancer
    Lin, Y.
    Zhang, X.
    He, H.
    Huang, L.
    Ding, S.
    Kai, Z.
    Lin, R.
    Luo, P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1300 - S1300
  • [10] A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma
    Sehgal, Kartik
    Serritella, Anthony
    Liu, Mofei
    Oneill, Anne
    Nangia, Chaitali
    Pappa, Theodora
    Demeure, Michael J.
    Worden, Francis P.
    Haddad, Robert I.
    Lorch, Jochen
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
12345